Qijian Huang – Trademark Portfolio

Entity Type: 01

Qijian Huang holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DQCQ, SQTV, and YBFQ. The owner is based in Fujian Province.

No. 92 Jianshe Street, Tingzhou Town

Changting County

Fujian Province 366399 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

DQCQ
DQCQ
Registered 2024
SQTV
SQTV
Registered 2024
YBFQ
YBFQ
Registered 2024

Trademark Classifications

Qijian Huang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Qijian Huang have?

Qijian Huang has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.

What trademark classes does Qijian Huang file in?

Qijian Huang files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Qijian Huang's most well-known trademarks?

Qijian Huang's registered trademark portfolio includes well-known marks such as DQCQ, SQTV, and YBFQ. These are among 3 currently registered trademarks in the portfolio.

What is Qijian Huang's trademark registration success rate?

Qijian Huang has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.